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Background: In patients with symptomatic severe aortic stenosis, advanced age is often a reason for a
transcatheter rather than surgical aortic valve replacement. In this pre-transcathter cohort we had the unique
oportunity to study outcomes after surgical aortic valve replacement for severe aortic stenosis in patients who
might currently be triaged to a percutaneous approach.
Methods: In a prospective single-center cohort study we compared the incidence of peri-operative complications,
mortality, and health-related quality of life in octogenarians versus patients aged <80 years. The quality of life was
measured using the SF-36 questionnaire and expressed as a physical and mental component score (PCS and MCS
respectively); a score of 50 equals the average score in the age-matched general population. The association
between age and the component scores at one-year follow-up was studied with the use of linear regression,
corrected for a set of confounding variables.
Results: We included 762 patients, of whom 21.4 % was aged >80 and 49.0 % underwent concomitant revascularization.
In octogenarians, the incidence of post-operative delirium was 11.0 %, which was higher than in patients aged below 80
(6.2 %, p= 0.034); the operative mortality (1.9 % vs. 2.9 %; p = 0.59) and long-term survival were not different however
(log-rank p = 0.75). In octogenarians, the quality of life was impaired 30-days after surgery (PCS 45.01, p <0.001;
MCS 48.21, p = 0.04), which improved towards or above normal values at one-year follow-up (PCS: 49.92, p = 0.67,
MCS: 52.55, p < 0.001). After correction for confounding, age was not significantly associated with the one-year
PCS (β 0.08 per year, p = 0.34) or MCS (β 0.08 per year, p = 0.32).
Conclusions: This pre-transcatheter study showed that surgical aortic valve replacement in octogenarians could
be performed with very low mortality, and with a relevant and significant increase of the quality of life towards
normal values. Also, age was not associated with a lower PCS or MCS one-year after surgery.
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Surgical aortic valve replacement (AVR) has long been the
only effective treatment for symptomatic severe aortic
stenosis (AS) [1–3]. The introduction of catheter-based
techniques questioned existing treatment strategies for
patients with AS. One obvious, but difficult challenge is
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intervention remains the treatment of choice. Based on the
results of four randomized trials [4–7] and multiple regis-
tries, current guidelines recommend TAVR in patients who
are either not suitable for surgery or have a very high surgi-
cal risk [2, 8]. These recommendations leave room for
interpretation and in daily clinical practice advanced age
alone is often the reason to prefer a percutaneous approach
[9]. This may indicate that physicians expect a poorer out-
come after surgical AVR in elderly patients.
In this study we investigate data from a large cohort of
surgical AVR patients that underwent surgery before
TAVR became available in our clinic. We will hence nots article is distributed under the terms of the Creative Commons Attribution 4.0
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the unique opportunity to assess outcomes of surgical
AVR in patients who may nowadays be triaged to a per-
cutaneous approach.
The aim of our study was to investigate the influence of
age on postoperative outcomes, in particular comparing
octogenarians to younger patients. Additional to post-
operative complications and long-term mortality we also
studied the health-related quality of life (HRQoL) after
one year, an outcome increasingly recognized as an out-
come of importance [2], and its change from baseline
HRQoL for patients of different age groups.
Methods
In this prospective, observational cohort study we included
consecutive patients with symptomatic AS who underwent
elective surgery for aortic stenosis, either isolated AVR or
AVR with concomitant coronary artery bypass grafting
(CABG). Patients were operated in a single institution (Isala
clinics, Zwolle, The Netherlands) between November 1st
2007 and August 1st 2011. During this period, the institu-
tion did not perform percutaneous procedures yet; there-
fore, patients who would currently be considered for a
percutaneous approach were part in this surgical cohort.
Patients gave written informed consent for the system-
atic collection of data in an ongoing registry of cardio-
thoracic surgery in our institution. We excluded patients
who refused informed consent, who had a non-stenotic
valve, active endocarditis or a previous AVR during the
study period from our analysis. The institution’s ethical
committee approved the protocol (reference: 12.0881n)
and waived the need for formal evaluation according to
the Dutch Law on Scientific Medical Research with
Humans. Data were anonymized before data analysis, and
the study conforms to the principles outlined in the
Helsinki declaration.
Data collection and end-points
Data were collected in an ongoing registry, which included
baseline characteristics, perioperative data, in-hospital out-
comes, and follow-up for clinical events and quality of life
until one year after surgery. The aortic peak gradient was
retrospectively registered through a review of electronic
charts. End-points were reported according to the “Valve
Academic Research Consortium-2 (VARC-2) criteria [10].
In-hospital stroke was diagnosed by an attending neurolo-
gist, and usually supported by cerebral computed tomog-
raphy imaging. Presence and severity of postoperative
kidney injury were defined according to the Acute Kidney
Injury Network (AKIN) classification [11]. Delirium was
assessed using the delirium observation screening (DOS)
scale, which was performed daily until hospital discharge.
Operative mortality was defined as 30-day mortality or in-
hospital mortality if postoperative hospital stay exceeded30 days. Long-term all-cause mortality was extracted from
the Dutch Municipal Personal Records Database on April
6th, 2012.
The HRQoL was measured with the Medical Outcomes
Study Short-Form 36 (SF-36), a widely used and well-
validated self-administered instrument [12, 13]. Patients
completed the test preoperatively, and at 30-days and one
year after intervention. According to the guidelines for
this instrument the 36 questions were subsequently
grouped into eight health scales (physical functioning,
role-physical, bodily pain, general health, vitality, social
functioning, role-emotional, and mental health) and two
summary measures (the physical component score [PCS]
and mental component score [MCS]).
Statistical analysis
Throughout the analyses we compared octogenarians (de-
fined as an age ≥80 years) with patients aged less than
80 years. The baseline characteristics and in-hospital out-
comes are presented as frequencies and percentages of total
for dichotomous variables, as the mean and standard devi-
ation (SD) for normally distributed data or the median and
interquartile range (IQR) for non-normally distributed data
respectively. Differences in categorical variables were
assessed as appropriate with a chi-square test or a Fisher’s
exact test. Differences in continuous variables were tested
using a Students’ t-test or Mann–Whitney-U test. Survival
plots were calculated with Kaplan-Meier (KM) statistics, as
a reference we also depicted the predicted survival of age-
and sex matched Dutch inhabitants reported by Statistics
Netherlands (www.cbs.nl). Differences in KM-estimated
survival were tested with a log-rank test.
The PCS and MCS were normalized such that a score
of 50 (standard deviation [SD] 10) equalled the mean
score of an age-matched Dutch reference population
[13]. We calculated the difference between the summary
scores at baseline versus the scores at 30-days and one
year follow-up, and tested these differences with a paired
t-test. Also, we tested for a difference in the change in
summary scores in octogenarians compared to younger
patients using an independent samples t-test, which was
corrected for the baseline scores.
To study the clinical relevance of a difference (rather
than only statistical significance) we also calculated
Cohen’s effect size by dividing the difference between
two measurements through the SD at baseline. Further-
more, we calculated the percentage of patients in whom
a minimal clinically important difference (MCID) was
observed, defined as a difference ≥2.5 points above or
below the baseline score [14].
Finally, we studied the influence of age on the difference
in the component scores at one-year follow-up compared
to baseline. The respective scores of the PCS and MCS
were included as the dependent variable in a univariable
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and were then corrected for several predefined covariables
(see Additional file 1). Sex was included in the multivari-
able model to study gender specific changes. Furthermore,
the baseline component scores were also included, since
patients with higher baseline scores generally improve less
on follow-up measurements than patients with lower
baseline scores [15].
Missing data were imputed since data are usually not
missing completely at random, but rather selectively [16,
17]. Discarding patients with missing data may lead to
biased results and furthermore a loss in precision [16, 17].
Imputation was performed in SPSS using five imputed
datasets, and then pooled using Rubin’s rule (see Additional
file 1 for imputation model). Throughout the analysis a
level of significance of 0.05 was used. Analyses were per-
formed in SPSS Statistics version 21.0.0 and R version
2.13.1.
Results
Characteristics of the patients
During the inclusion period, 5,069 cardiothoracic opera-
tions were performed, of which 862 were isolated AVR or
AVR with concomitant CABG. Twenty-three patients were
excluded because they refused consent for the registration;
another 77 patients met one or more of the exclusion
criteria (Fig. 1). The final study population thus comprisedFig. 1 Study flowchart and follow-up. Legend: Patients were included betw
were excluded in total; five patients met two exclusion criteria, i.e. active en
CABG = coronary artery bypass grafting, FU = follow-up762 patients. Follow-up of the vital status was completed in
757 (99.3 %) of patients, with a median follow-up of
2.4 years (IQR 1.0–3.3). Follow-up of the SF-36 was
completed by 82.2 % of patients at baseline, by 83.9 % at
30-days follow-up and 84.7 % of patients at one-year
follow-up. The baseline characteristics of patients with and
without missing one-year follow-up of the SF-36 question-
naire are shown in Additional file 2.
One-hundred and sixty-three patients (21.4 %) were aged
80 years or over at the date of surgery; median age of this
group was 82 years, with a female predominance of 52.1 %.
Octogenarians had a lower systolic left ventricular function
than younger patients (p = 0.044), other baseline character-
istics were not significantly different (Table 1). A bioprosth-
esis was implanted more often in octogenarians than in
non-octogenarians (97.6 % vs. 90.6 %, p <0.001); the total
cross-clamp time was shorter (82 vs. 91 min, p = 0.004),
and combined surgery with CABG occurred in almost half
of the procedures in both age groups less frequently
(46.0 % vs. 49.9 %, p = 0.426). The EuroSCORE I predicted
risk of operative mortality was higher in octogenarians than
in patients aged below 80 years (10.7 % vs. 4.9 %, p < 0.001).
In-hospital outcomes and mortality
During hospitalization, octogenarians more frequently
developed a delirium (11.0 % vs. 6.2 %, p = 0.034), and
total hospital-stay was longer (median (IQR) of 7 (5–9)een November 1st 2007 and August 1st 2011*One hundred patients
docarditis and non-elective surgery. AVR = aortic valve replacement,
Table 1 Baseline characteristics and operative characteristics
Age < 80 Age ≥ 80
N = 597 N = 163 P
Male sex 363 (60.8) 85 (52.1) 0.057
Age, years 71 (66–75) 82 (81–83) <0.001
History of:
DM 145 (24.4) 37 (22.7) 0.727
Hypertension 325 (54.4) 98 (60.1) 0.228
COPD 116 (19.4) 30 (18.4) 0.855
Peripheral VD 70 (11.7) 17 (10.4) 0.748
Stroke 66 (11.1) 20 (12.3) 0.768
MI 74 (12.4) 21 (12.9) 0.979
PCI 65 (10.9) 18 (11.0) 1.000
Cardiac surgery 42 (7.0) 8 (4.9) 0.428
Creatinine (mmol/L) 88 (75–104) 92 (77–110) 0.001
EuroSCORE 6 (5–7) 8 (8–10) <0.001
Log EuroSCORE 4.9 (3.1–7.6) 10.7 (8.4–15.7) <0.001
LVEF >50 % 468 (78.7) 113 (69.3) 0.044
30–50 % 103 (17.3) 40 (24.5)
<30 % 24 (4.0) 10 (6.1)
NYHA Class 1 145 (24.3) 45 (27.6) 0.149
Class 2 342 (57.4) 80 (49.1)
Class 3 109 (18.3) 38 (23.3)
Peak gradient AV (mmHg) 73 (60–90) 71 (58–88) 0.55
Operative characteristics
Bioprosthesis 541 (90.6) 159 (97.6) <0.001
CABG 298 (49.9) 75 (46.0) 0.426
X-clamp time (min) 91 (75–111) 82 (68–107) 0.004
Baseline chararcteristics and operative characteristics in octogenarians and
patients aged less than 80 years. Values are number (%), continuous variables
are presented as median (25th–75th percentile)
DM diabetes mellitus, COPD chronic obstructive pulmonary disease, VD
vascular disease, MI myocardial infarction, PCI percutanaeous coronary
intervention, LVEF left ventricular ejection fraction, NYHA New York Heart
Association, AV aortic valve, peak gradient = maximum gradient over the aortic
valve, CABG coronary artery bypass grafting
Table 2 Patient outcomes
Age < 80 Age ≥ 80
N = 597 N = 163 P
In-hospital Outcomes
Delirium 37 (6.2) 18 (11.0) 0.034
Stroke 21 (3.5) 5 (3.1) 0.97
MI 17 (3.0) 4 (2.6) 1.00a
AKIN No injury 537 (92.4) 148 (90.8) 0.22
Stage 1 36 (6.2) 12 (7.4)
Stage 2 5 (0.9) 0 (0)
Stage 3 3 (0.5) 3 (1.8)
Hospital stay (days) 7 (5–9) 7 (5–12) 0.031
Mortality
In-hospital 13 (2.2) 2 (1.2) 0.75a
Operative 17 (2.9) 3 (1.9) 0.59a
1-Year 33 (6.3) 9 (6.5) 1.00
Comparison of operative chararcteristics and patient outcomes. Operative
mortality is either 30-day or in-hospital mortality
MI myocardial infarction, AKIN acute kidney injury network
a Fisher’s Exact test
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dence of stroke (3.1 % vs. 3.5 %, p = 0.97), myocardial
infarction (2.6 % vs. 3.0 %, p = 1.00) and acute kidney
injury (9.2 % vs. 7.6 %, p = 0.22) did not differ signifi-
cantly between the two groups. Two octogenarians died
before hospital discharge, one additional patient died
within 30-days of surgery, thus the operative mortality was
1.9 %, compared to 2.9 % in patients aged <80 (p = 0.59).
Both one-year mortality (6.5 % vs. 6.3 %, p = 1.00) and
long-term mortality were similar for octogenarians and
patients aged < 80 years (log-rank p = 0.745; Fig. 2).
Health-related quality of life
The PCS in octogenarians was 44.68 at baseline, which was
lower than the average score of 50 in the age-matchedreference population (p <0.001; Table 3). The PCS
remained impaired 30-days after surgery (45.01, p <0.001)
but improved towards a normal level one year after sur-
gery (49.92, p = 0.67). The one-year PCS in octogenar-
ians was also comparable to patients aged below 80
(49.92 vs. 51.34, p = 0.12), but the increase from base-
line was smaller in octogenarians (4.84 vs. 6.95, p =
0.04), as was Cohen’s D (0.54 vs. 0.78, p = 0.04).
The MCS in octogenarians was 51.17 at baseline, which
was higher than the average score in the reference popula-
tion (p = 0.04). Thirty-days after surgery the MCS had
reduced towards a below-average score (48.21, p = 0.04),
but at one-year follow-up the MCS was again above ex-
pected (52.55, p < 0.001). The MCS one year after surgery
was also higher in octogenarians compared to patients
aged below 80 years (MCS 52.55 vs. 50.83, p < 0.001);
however, the increase from baseline was similar (1.31 vs.
1.67, p = 0.38) and Cohen’s effect size was lower (0.14 vs.
0.22, p = 0.01).
Association between age and HRQoL
Increasing age was associated with a higher PCS at 30-days
follow-up, both in a univariable model (β 0.20 per year,
95 % CI: 0.14–0.27, p <0.001) and when corrected for base-
line characteristics (β 0.30, 95 % CI: 0.08–0.15, p <0.001;
Table 4). One year after surgery age was however not asso-
ciated with the PCS (multivariable model: β 0.08, 95 %
CI: −0.11–0.16, p = 0.34). Also, age was not associated
with the MCS at 30-days follow-up (β -0.07, 95 % CI:
−0.22–0.83, p = 0.37), or 1-year after surgery (β 0.08,
95 % CI: −0.08–0.25, p = 0.32).
Fig. 2 Long-term survival after aortic valve replacement. Legend: Kaplan-Meier estimated survival in octogenarians (red line and 95 % confidence
interval [CI]) compared to patients aged <80 years (green line and 95 % CI); as a reference the dotted black lines depict the predicted survival for
Dutch inhabitants with a similar distribution of age and sex as the two study groups
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This study of pre-TAVR patients showed that surgical
AVR in octogenarians could be performed with very low
postoperative mortality, and a relevant and significant
increase of the HRQoL towards normal values. Also, age
was not associated with a lower PCS or MCS one-year
after surgery.Outcomes and survival
Post-operative delirium was more often observed in
octogenarians compared to younger patients (11.0 % vs.
6.2 %, p = 0.03), which may reflect an increased vulner-
ability of the aging brain for ischemic cerebral damage.
Several perioperative processes are associated with this
type of injury, including the embolization of particulate
emboli, hypotension and inflammation [18]. Indeed, age
was previously found to be one of the most important
risk-factors for post-operative delirium [19]. However,
the incidence of stroke, which is regarded to be in theTable 3 Health-related quality of life in patients undergoing surgica
Baseline 30 days









Age < 80 44.27 44.11 −0.16 0.73 −0.02 39.0
Age > 80 44.86 45.01 0.09† 0.93 0.01 40.1
MCS
Age < 80 49.12 48.33 −0.81 0.073 −0.52 36.2
Age > 80 51.17 48.21 −2.96† 0.002 −0.64 32.5
aThe “change from baseline” in octogenarians was compared to patients aged <80
component score, where † indicates p > 0.05
bAn effect size of <0.20 can be considered as clinically irrelevant, 0.20–0.49 as smal
MCS =mental component score, MCID =minimal clinically important differencesame spectrum of cerebral (embolic) injury as delirium,
was not increased in octogenarians.
Mortality rates were low, with an observed operative
mortality of 1.9 % in octogenarians and 2.9 % (p = 0.59)
in younger patients. These rates are considerably lower
than reported in previous studies, which ranged from
4.0–16 % [20–23]. One year after surgery 93.5 % of octo-
genarians were alive, and the long-term survival up to
4 years after surgery was similar compared to younger
patients. These outcomes contrast with the grim prog-
nosis of medically treated severe AS [1], and based on
our results one may question if age alone is a valid
motivation to either refrain from surgery or to prefer a
percutaneous treatment. Interestingly, from one year after
surgery onwards, the long-term survival of octogenarians
was better than that of Dutch inhabitants of the same age
and sex. Although it is well accepted that surgery for aor-
tic stenosis improves life expectancy, the improved per-
formance compared to the general population is likely to
also indicate the selection of a healthy population in ourl AVR
1 year








51.34 6.95 <0.001 0.78 66.8
49.92 4.84† <0.001 0.54 60.7
50.83 1.67 0.006 0.22 44.2
52.55 1.31† 0.126 0.14 39.6
years using an independent samples t test and corrected for the baseline
l, 0.50–0.79 as moderate and > 0.80 as large. PCS = physical component score,
Table 4 Association between age and the PCS and MCS scores at 30 days and 1 year follow-up
PCS – 30 days PCS – 1 year
β (95 % CI) P β (95 % CI) P
Age 0.20 (0.14–0.27) <0.001 −0.00 (−0.11–0.10) 0.90
Age (+ baseline PCS) 0.16 (0.10–0.22) <0.001 −0.07 (−0.17–0.04) 0.19
Age (full model) 0.30 (0.08–0.15) <0.001 0.08 (−0.11–0.16) 0.34
MCS – 30 days MCS – 1 year
β (95 % CI) P β (95 % CI) P
Age −0.05 (−0.14–0.03) 0.22 0.07 (−0.02–0.15) 0.11
Age (+ baseline) −0.08 (−0.16–0.00) 0.05 0.05 (−0.03–0.14) 0.20
Age (full model) −0.07 (−0.22–0.83) 0.37 0.08 (−0.08–0.25) 0.32
Table shows the univariable and multivariably adjusted asociation between age and the component scores; the full model also included: sex, chronic obstructive
pulmonary disease, diabetes mellitus, extracardiac atherosclerosis, history of stroke, history of myocardial infarction, previous percutaneous coronary intervention,
previous cardic surgery, NYHA class, CCS class, left ventricular function, concomitant coronary artery bypass grafting, aortic peak gradient, logistic EuroSCORE and
baseline physical component score for the PCS model, or baseline mental component score for the MCS model. PCS = physical component score, MCS =mental
component score
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our study. Yet, over 20 % of patients was aged ≥80 years,
which is in the higher range of other registries, and indi-
cates a pro-active attitude towards surgical management in
these patients [20, 22]. Also, we included patients with
concomitant revascularization as recommended, since both
survival and HRQoL are known to be reduced in these
patients [24].
Health-related quality of life
One month after surgery the PCS and MCS seemed to
decrease rather than to improve, which may be related to
the burdensome effects associated with sternotomy. This
was also shown in the PARTNER trial, which randomly al-
located patients to a surgical or percutaneous AVR. In that
study, one month after intervention the HRQoL had in-
creased in the latter, but not in the former group [25].
However, at 6 and 12 months follow-up a similar increase
of the PCS was observed after both approaches. Similarly
in our study, the PCS and MCS one year after surgery had
increased relevantly and significantly towards a level ex-
pected for the reference population.
Association between age and HrQoL
Age was not associated with the PCS score at thirty days
and one-year follow-up. Furthermore, age was positively
associated with the MCS at 30-days follow-up. Although
the reasons for this positive association have to be specu-
lated, these results indicate that older patients can expect
a relative quality of life at least similar to younger patients.
As expected, a higher baseline component score was
associated with a lower component score at one-year
follow-up. This is probably caused by regression to the
mean, as was described previously in the serial analysis
of HRQoL measurements [15]. That is, patients who
already have a high baseline score are less likely to havean even higher score at follow-up, while patients with a
low baseline score are less likely to have an even lower
score. To correct for this potential bias, we included the
baseline component scales in the multivariable linear
regression analyses.
Limitations
The results of this study should be appreciated with
consideration of its limitations. First, as in any observa-
tional study, the efficacy of the intervention itself could
not be studied, as this would require a control group of
similar patients without surgical AVR. However, as a
general reference, we compared both the survival and
HRQoL to a matched general population. Long-term
survival in octogenarians was better than expected for
age- and sex matched Dutch inhabitants, which is likely
to indicate that the octogenarians selected as suitable
candidates for surgery were in relative good physical
health. Yet, as mentioned, the proportion of octogenar-
ians in our study is comparable to other registries. Also,
mortality was well below predicted based on the
original EuroSCORE.
One-year follow-up of the SF-36 questionnaire was
missing in approximately 15 % of patients. Missing
follow-up status was associated a higher preoperative
EuroSCORE, but this difference was non-significant
within patients alive at one-year (i.e. missingness not
due to mortality; Additional file 2). In such a situation
where data are not “missing completely at random”, it
has been recommended to multiply impute missing
data [17]. In a sensitivity analysis that included patients
with complete cases only, our results did not change
substantially (Additional file 3).
Finally, as recommended by the VARC-2 criteria, postop-
erative kidney injury was defined according to the AKIN
classification in which kidney injury is categorized both
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falls in the worse category) [10]. The latter was not re-
corded however, which may thus have resulted in misclassi-
fication of patients.Conclusion
This study of pre-TAVR patients showed that surgical AVR
in octogenarians could be performed with very low mortal-
ity and a relevant and significant increase of the quality of
life towards normal values. Age was not associated with a
lower PCS or MCS one-year after surgery after adjustment
for comorbidities. Hence, based on these results, age by
itself does not serve as a contraindication for surgical AVR.Additional files
Additional file 1: Variables included in the multivariable and imputational
models. (DOCX 89 kb)
Additional file 2: Baseline characteristics of patients with missing follow-up
of SF-36 data. (DOCX 88 kb)
Additional file 3: SF-36 complete case analyses. (DOCX 73 kb)Abbreviations
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